Avacta Group (LON:AVCT) Stock Price Passes Below Two Hundred Day Moving Average – Here’s Why

Avacta Group Plc (LON:AVCTGet Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 58.93 ($0.72) and traded as low as GBX 51 ($0.62). Avacta Group shares last traded at GBX 52 ($0.64), with a volume of 1,090,990 shares traded.

Avacta Group Trading Down 1.5 %

The business has a 50-day moving average price of GBX 48.60 and a 200-day moving average price of GBX 58.84. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 63.54. The firm has a market capitalization of Ā£178.24 million, a P/E ratio of -552.72 and a beta of 1.12.

Avacta Group Company Profile

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISIONĀ® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Recommended Stories

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.